MiR-33a-5p inhibits the growth and metastasis of melanoma cells by targeting SNAI2.

In conclusion, miR-33a-5p repressed the progression of melanoma by targeting SNAI2 via inactivation of the PI3K/AKT/mTOR signaling pathway, providing a potential molecular mechanism for the treatment of melanoma.
PMID: 32305057 [PubMed - as supplied by publisher]

Source: Neoplasma - April 15, 2020 Category: Cancer & Oncology Authors: Zhang ZR, Yang N Tags: Neoplasma Source Type: research